论文信息 - SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer - 字舞流文

SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

G. Rustin | P. Vasey | S. Kaye | D. Parkin | N. Reed | J. Paul | R. Symonds | L. Lewsley | R. Osborne | R. Coleman | R. Atkinson